Akorn Inc's ability to collect accounts receivable sequentially worsen to 4.46, indicating more challenging environment then in the first quarter 2020, but still, it is a far cry from any concerns. Akorn Inc's Accounts Receivable average collection period in the Jun 30 2020 quarter, has increased to 82 days, from 81 days, in the Mar 31 2020 quarter.

If we take a look into Healthcare sector 214 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1871, from overall ranking in the first quarter 2020 at 2960.

What is Receivable Turnover Ratio?
What is Akorn Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AKRXQ Receivables Turnover Ratio	(Jun 30 2020) II. Quarter	(Mar 31 2020) I. Quarter	(Dec 31 2019) IV. Quarter	(Sep 30 2019) III. Quarter	(Jun 30 2019) II. Quarter
Y / Y Receivable Change	-23.91 %	7.4 %	-12.38 %	-12.73 %	-7.85 %
Y / Y Revenue Change	-32.43 %	23.4 %	5.78 %	6.41 %	-6.75 %
Receivable Turnover Ratio (TTM)	4.46	4.53	4.37	4.19	3.99
AKRXQ's Total Ranking	# 1871	# 2960	# 1871	# 2961	# 1871
Accounts Receivable average collection period days	82	81	83	87	91
Seq. Receivable Change	-29.85 %	39.53 %	-6.09 %	-17.23 %	-0.98 %
Seq. Revenue Change	-41.22 %	26.15 %	-7.94 %	-1.02 %	7.35 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 51
Healthcare Sector	# 215
Overall Market	# 1871

Receivable Turnover Ratio Statistics
High	Average	Low
0.79	0.47	0.17
(Mar 31 2014)		(Dec 31 2015)

AKRXQ Company Profile • Back to AKRXQ Efficiency Comparisons • Compare AKRXQ Receivables Turnover Ratio to its Competitors

Financial Statements
Akorn Inc's Accounts Receivable	$ 131 Millions	Visit AKRXQ's Balance sheet
Akorn Inc's Sales TTM	$ 664 Millions	Visit AKRXQ's Income Statement
Sources of AKRXQ's Revenues		Visit AKRXQ's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AKRXQ's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AKRXQ's Growth Rates	AKRXQ's Roa	AKRXQ's Inventory Turnover Ratio	AKRXQ's Dividend Comparisons
AKRXQ's Profitability Ratios	AKRXQ's Roi	AKRXQ's Asset Turnover Ratio	AKRXQ's Dividend Growth
AKRXQ's Valuation Ratios	AKRXQ's Roe	AKRXQ's Financial Strength Ratios	AKRXQ's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2020, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2020	Receivable at quarter ending Jun 30 2020
Prothena Corporation Public Limited Company	13.86	$ 0.797 Millions	$ 0.057 Millions
Tvardi Therapeutics Inc	13.74	$ 24.023 Millions	$ 1.749 Millions
Myomo Inc	13.68	$ 3.994 Millions	$ 0.292 Millions
Seres Therapeutics Inc	13.57	$ 28.887 Millions	$ 2.129 Millions
Vbi Vaccines Inc	13.21	$ 1.820 Millions	$ 0.138 Millions
Beam Therapeutics Inc	12.50	$ 1,334.499 Millions	$ 106.756 Millions
Ardelyx inc	12.32	$ 8.312 Millions	$ 0.675 Millions
Patterson Companies Inc	11.87	$ 5,407.197 Millions	$ 455.346 Millions
Imac Holdings Inc	11.72	$ 14.494 Millions	$ 1.237 Millions
Integrated Biopharma Inc	11.72	$ 52.769 Millions	$ 4.503 Millions
Sunlink Health Systems Inc	11.41	$ 59.184 Millions	$ 5.189 Millions
Travere Therapeutics Inc	11.18	$ 187.260 Millions	$ 16.748 Millions
Dmk Pharmaceuticals Corporation	11.14	$ 20.033 Millions	$ 1.798 Millions
Zevra Therapeutics Inc	11.11	$ 21.836 Millions	$ 1.965 Millions
Lifeloc Technologies Inc	11.07	$ 7.684 Millions	$ 0.694 Millions
Regeneron Pharmaceuticals Inc	11.05	$ 7,998.100 Millions	$ 723.725 Millions
Dariohealth Corp	11.00	$ 7.120 Millions	$ 0.647 Millions
Durect Corp	11.00	$ 50.067 Millions	$ 4.553 Millions
Teladoc Health Inc	10.99	$ 690.074 Millions	$ 62.767 Millions
Mersana Therapeutics inc	10.83	$ 0.807 Millions	$ 0.075 Millions
National Healthcare Corp	10.79	$ 1,018.713 Millions	$ 94.403 Millions
La Jolla Pharmaceutical Company	10.79	$ 26.352 Millions	$ 2.443 Millions
Adamas Pharmaceuticals Inc	10.74	$ 63.556 Millions	$ 5.915 Millions
Affimed N v	10.65	$ 3.232 Millions	$ 0.304 Millions
American Bio Medica Corporation	10.60	$ 4.261 Millions	$ 0.402 Millions
Sanara Medtech Inc	10.41	$ 12.754 Millions	$ 1.225 Millions
Insulet Corporation	10.37	$ 825.809 Millions	$ 79.609 Millions
Option Care Health Inc	10.28	$ 3,386.232 Millions	$ 329.535 Millions
Miragen Therapeutics Inc	10.26	$ 4.257 Millions	$ 0.415 Millions
Agenus Inc	10.19	$ 96.515 Millions	$ 9.473 Millions

Date modified: 2026-08-29T17:34:59+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.